Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Sales

NewGenIvf (NIVF) Return on Sales: 2021-2024

Historic Return on Sales for NewGenIvf (NIVF) over the last 4 years, with FY2024 value amounting to 0.09%.

  • NewGenIvf's Return on Sales rose 130800.0% to 13.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.01%, marking a year-over-year change of. This contributed to the annual value of 0.09% for FY2024, which is 1100.0% down from last year.
  • As of FY2024, NewGenIvf's Return on Sales stood at 0.09%, which was down 1100.0% from 0.02% recorded in FY2023.
  • In the past 5 years, NewGenIvf's Return on Sales registered a high of 0.02% during FY2022, and its lowest value of 0.09% during FY2024.
  • For the 4-year period, NewGenIvf's Return on Sales averaged around 0.02%, with its median value being 0.01% (2021).
  • Its Return on Sales has fluctuated over the past 5 years, first surged by 600bps in 2022, then crashed by -1100bps in 2024.
  • Annual analysis of 4 years shows NewGenIvf's Return on Sales stood at 0.03% in 2021, then skyrocketed by 168bps to 0.02% in 2022, then decreased by -8bps to 0.02% in 2023, then crashed by -513bps to 0.09% in 2024.
  • Its Return on Sales stands at 0.09% for FY2024, versus 0.02% for FY2023 and 0.02% for FY2022.